https://www.selleckchem.com/pr....oducts/upadacitinib.
In a subgroup analysis, the incidence of COM in all age groups and in men and women was significantly higher in the CRS group than in the control group. More, CRS increased the risk of COM. A significant association was observed between CRS and COM. This indicates that CRS patients have a high risk of developing COM. A significant association was observed between CRS and COM. This indicates that CRS patients have a high risk of developing COM. Advanced therapies, including cell and gene therapies, have shown therapeutic promise in
Like
Comment
Share
